Argent Biopharma Ltd (MGCLF): who could it be? September 2018 Au...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	34
Boards Moderated	0
Alias Born	12/06/2017

Bigarm

Re: None

Thursday, 09/20/2018 9:34:43 PM

Thursday, September 20, 2018 9:34:43 PM

who could it be?

September 2018
Australian Securities Exchange Level 40, Central Park 152-158 St Georges Tce
Perth WA 6000
Via email: tradinghaltsperth@asx.com.au
Dear Sir/Madam
The Directors of MGC Pharmaceuticals Ltd (the “Company”) request that the Company’s securities be placed in a voluntary trading halt immediately in accordance with ASX Listing Rule 17.1, pending the release of an announcement by the Company regarding a material commercial transaction with a Canadian cannabis company.
The Company requests that the trading halt end on the earlier of the commencement of normal trading on Tuesday 25 September 2018, or when the announcement referred to above is released to the market.
The Company is not aware of any reason why the trading halt should not be granted, nor of any other information necessary to inform the market about the trading halt, and the Company confirms that the request for a trading halt is material.
Yours faithfully
Brett Mitchell Executive Chairman